Mesenchymal stem cells for repairing glaucomatous optic nerve

10Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Glaucoma is a common and complex neurodegenerative disease characterized by progressive loss of retinal ganglion cells (RGCs) and axons. Currently, there is no effective method to address the cause of RGCs degeneration. However, studies on neuroprotective strategies for optic neuropathy have increased in recent years. Cell replacement and neuroprotection are major strategies for treating glaucoma and optic neuropathy. Regenerative medicine research into the repair of optic nerve damage using stem cells has received considerable attention. Stem cells possess the potential for multidirectional differentiation abilities and are capable of producing RGCfriendly microenvironments through paracrine effects. This article reviews a thorough researches of recent advances and approaches in stem cell repair of optic nerve injury, raising the controversies and unresolved issues surrounding the future of stem cells.

Cite

CITATION STYLE

APA

Hu, B. Y., Xin, M., Chen, M., Yu, P., & Zeng, L. Z. (2024, April 18). Mesenchymal stem cells for repairing glaucomatous optic nerve. International Journal of Ophthalmology. International Journal of Ophthalmology (c/o Editorial Office). https://doi.org/10.18240/ijo.2024.04.20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free